- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-IL-6R alpha
IL-6R alpha Polyclonal Antibody for WB, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IP, IF, IHC, ELISA
Conjugaison
Non conjugué
N° de cat : 23457-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules Jurkat, tissu splénique de rat, tissu splénique de souris |
Résultats positifs en IP | tissu splénique de souris |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 22 publications below |
IHC | See 4 publications below |
IF | See 7 publications below |
Informations sur le produit
23457-1-AP cible IL-6R alpha dans les applications de WB, IP, IF, IHC, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | IL-6R alpha Protéine recombinante Ag18263 |
Nom complet | interleukin 6 receptor |
Masse moléculaire calculée | 468 aa, 52 kDa |
Poids moléculaire observé | 80 kDa |
Numéro d’acquisition GenBank | BC132684 |
Symbole du gène | IL-6R alpha |
Identification du gène (NCBI) | 3570 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Interleukin-6 (IL-6) is a pleiotropic cytokine produced by a variety of cells during infection, trauma, and immunological challenge (PMID: 8274730). IL-6 acts via a receptor complex consisting of two distinct membrane-bound glycoproteins, an 80-kDa IL-6-binding subunit (IL-6R alpha, CD126, gp80) and a 130-kDa signal-transducing element (gp130, CD130). After binding of IL-6 to membrane-bound IL-6R alpha, the complex of IL-6 and IL-6R alpha associates with gp130, thus activating the receptor (PMID: 9716487). Expression of gp130 is found in almost all organs while expression of IL-6R alpha is predominantly confined to hepatocytes and leukocyte subpopulations (monocytes, neutrophils, T cells, and B cells) (PMID: 11149892). Soluble form of IL-6R alpha has been found in human serum and urine (PMID: 2529343; 1545125).
Protocole
Product Specific Protocols | |
---|---|
WB protocol for IL-6R alpha antibody 23457-1-AP | Download protocol |
IP protocol for IL-6R alpha antibody 23457-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Signal Transduct Target Ther Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms | ||
Cancer Discov Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation. | ||
J Med Virol Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis | ||
Acta Pharmacol Sin Exosomes derived from induced cardiopulmonary progenitor cells alleviate acute lung injury in mice | ||
Allergol Int Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma. | ||
Pharmacol Res Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin. |